MicroRNAs and Apoptosis in Colorectal Cancer

被引:120
作者
Wang, Hsiuying [1 ]
机构
[1] Natl Chiao Tung Univ, Inst Stat, Hsinchu 30010, Taiwan
关键词
apoptosis; colorectal cancer; microRNA; resistance; COLON-CANCER; PROMOTES APOPTOSIS; TUMOR-SUPPRESSOR; DRUG-RESISTANCE; DOWN-REGULATION; CELL-PROLIFERATION; SMALL RNAS; EXPRESSION; 5-FLUOROURACIL; PROGRESSION;
D O I
10.3390/ijms21155353
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Colorectal cancer (CRC) is the third leading cause of cancer death in the world, and its incidence is rising in developing countries. Treatment with 5-Fluorouracil (5-FU) is known to improve survival in CRC patients. Most anti-cancer therapies trigger apoptosis induction to eliminate malignant cells. However, de-regulated apoptotic signaling allows cancer cells to escape this signaling, leading to therapeutic resistance. Treatment resistance is a major challenge in the development of effective therapies. The microRNAs (miRNAs) play important roles in CRC treatment resistance and CRC progression and apoptosis. This review discusses the role of miRNAs in contributing to the promotion or inhibition of apoptosis in CRC and the role of miRNAs in modulating treatment resistance in CRC cells.
引用
收藏
页码:1 / 15
页数:15
相关论文
共 133 条
[1]   The Bcl-2 apoptotic switch in cancer development and therapy [J].
Adams, J. M. ;
Cory, S. .
ONCOGENE, 2007, 26 (09) :1324-1337
[2]   Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp [J].
Alfarouk, Khalid O. ;
Stock, Christian-Martin ;
Taylor, Sophie ;
Walsh, Megan ;
Muddathir, Abdel Khalig ;
Verduzco, Daniel ;
Bashir, Adil H. H. ;
Mohammed, Osama Y. ;
Elhassan, Gamal O. ;
Harguindey, Salvador ;
Reshkin, Stephan J. ;
Ibrahim, Muntaser E. ;
Rauch, Cyril .
CANCER CELL INTERNATIONAL, 2015, 15
[3]   How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? [J].
Aubrey, Brandon J. ;
Kelly, Gemma L. ;
Janic, Ana ;
Herold, Marco J. ;
Strasser, Andreas .
CELL DEATH AND DIFFERENTIATION, 2018, 25 (01) :104-113
[4]   The APC/β-catenin pathway in ulcerative colitis-related colorectal carcinomas -: A mutational analysis [J].
Aust, DE ;
Terdiman, JP ;
Willenbucher, RF ;
Chang, CG ;
Molinaro-Clark, A ;
Baretton, GB ;
Loehrs, U ;
Waldman, FM .
CANCER, 2002, 94 (05) :1421-1427
[5]   Colorectal cancer is a leading cause of cancer incidence and mortality among adults younger than 50years in the USA: a SEER-based analysis with comparison to other young-onset cancers [J].
Bhandari, Abhishek ;
Woodhouse, Melissa ;
Gupta, Samir .
JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (02) :311-315
[6]  
Bhat AA, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01175-9
[7]   New therapeutic strategies to treat human cancers expressing mutant p53 proteins [J].
Blandino, Giovanni ;
Di Agostino, Silvia .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37
[8]   miR-143 Overexpression Impairs Growth of Human Colon Carcinoma Xenografts in Mice with Induction of Apoptosis and Inhibition of Proliferation [J].
Borralho, Pedro M. ;
Simoes, Andre E. S. ;
Gomes, Sofia E. ;
Lima, Raquel T. ;
Carvalho, Tania ;
Ferreira, Duarte M. S. ;
Vasconcelos, Maria H. ;
Castro, Rui E. ;
Rodrigues, Cecilia M. P. .
PLOS ONE, 2011, 6 (08)
[9]   SMAD7 is a prognostic marker in patients with colorectal cancer [J].
Boulay, JL ;
Mild, G ;
Lowy, A ;
Reuter, J ;
Lagrange, M ;
Terracciano, L ;
Laffer, U ;
Herrmann, R ;
Rochlitz, C .
INTERNATIONAL JOURNAL OF CANCER, 2003, 104 (04) :446-449
[10]   Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia [J].
Calin, GA ;
Dumitru, CD ;
Shimizu, M ;
Bichi, R ;
Zupo, S ;
Noch, E ;
Aldler, H ;
Rattan, S ;
Keating, M ;
Rai, K ;
Rassenti, L ;
Kipps, T ;
Negrini, M ;
Bullrich, F ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (24) :15524-15529